Asymmetric RBBP7 regulates the first cell fate decision of early mammalian embryos
Abstract
Asymmetric transcription of noncoding RNA LincGET is currently recognized as the earliest event regulating the first cell fate decision in mammalian embryogenesis. However, whether key protein factors modulate this process remains elusive. Here, we identify RBBP7 as the earliest protein factor regulating developmental cell fate in mammals. Loss of RBBP7 drives cells towards ICM lineage. In mouse late 2-cell embryos, unequal translation of Rbbp7 contributes to its asymmetric protein distribution, which subsequently induces inversed asymmetric histone acetylation H3K9ac by interaction with HDAC1, thereby promoting cell differentiation. Interestingly, RBBP7 and LincGET exhibit a consistent asymmetric tendency but direct different cell fates; depletion or overexpression of both Rbbp7 and LincGET restored the cell fate bias, suggesting a coordinated regulatory mechanism during initial lineage specification. In summary, our study reveals RBBP7 as a new protein factor and elucidates its role in the first cell fate decision.
// Source
Authors: Lin-Fang Ju, Xiao Han, Danru Zhang, Heng-Ji Xu, Shaokang Jia, Meng-Xia Liu, Yanchen Liu, Yu-Ting Cai, Yusheng Chen, Chun‐Chun Gao, Yongliang Zhao, Yajing Hao, Xiu‐Jie Wang, Dangsheng Li, Xiang Zhou, Ying Yang, Jianyong Han, Yun‐Gui Yang
Institutions: Chinese Academy of Sciences, University of Chinese Academy of Sciences, Wuhan University, China Agricultural University, Shandong University of Technology, Chinese Academy of Governance, Institute of Genetics and Developmental Biology, Sino-Danish Centre for Education and Research, Beijing Institute of Genomics, Center for Excellence in Molecular Cell Science, China National Biotechnology (China)